Features & Benefits
- Broad Coverage:
Utilizes more than 200 antibodies to develop 3-D conformational fingerprint.
- Intelligent Database:
Data analysis is supported by extensive databank containing 150+ innovator and biosimilar fingerprints.
- Artificial Intelligence Driven Data Analysis
- Glycan Profiling
- Predictive of Functional Activities:
- Target binding
- ADCC and CDC activity
- Fc Receptor binding
Intelli.b – Biosimilar Fingerprinting Technology
Somru BioScience has developed Intelli.b™ – a platform for the comparability testing of biosimilars at a molecular level that meets the intent of the FDA guidance for fingerprint-like analysis. The Intelli.b™ platform is an integrated, multi-parameter approach that is extremely sensitive in identifying analytical differences (i.e. fingerprint-like analysis).
Application of Intelli.b
Harness power of laboratory automation to boost your drug development studies.
Learn.
Engage.
Connect.
Learn | Engage | Connect
Read news, updates, and transforming technologies of drug development
Recommendations on ELISpot assay
Gene therapy, cell therapy and vaccine research have led to..
Read More ...Population Pharmacokinetics (PopPK) in
Population Pharmacokinetics (PopPK) in Biosimilar Studies: Purpose, Challenges, Solutions, and..
Read More ...Large Molecule Bioanalytical Services
Automation Our custom developed automation solutions can significantly improve quality,..
Read More ...Immunogenicity Assays
Immunogenicity Assays Solutions Off the shelf fully validated assays Proprietary..
Read More ...